About

About MedBioinformatics MedBioinformatics is the team behind DISGENET, the world’s most extensive gene-disease database, designed to accelerate drug R&D and precision medicine possibilities. DISGENET supports drug discovery by providing actionable insights on gene and genomic variants associated with human diseases. By facilitating tasks such as drug target identification, safety assessment, and drug repurposing, DISGENET accelerates the development of safer, more effective therapies. With 15 years of expertise, our team harnesses the power of AI, data analytics, and NLP to uncover insights from complex genomic data, enabling pharma and biotech to leverage the full potential of genomics and fast-track breakthrough therapies.